Healthy.io and Geisinger Present Milestone Data at AHA 2024

Company News Archives - Healthy

Introduction

At the American Heart Association (AHA) Scientific Sessions 2024, healthcare technology company Healthy.io and integrated healthcare provider Geisinger presented milestone data highlighting the impact of home-based kidney health screening. Their findings demonstrated how digital health solutions can help identify chronic kidney disease (CKD) earlier, improve patient participation in preventive care, and support better long-term health outcomes.

The collaboration reflects a growing trend in healthcare: using innovative, patient-friendly technologies to make preventive screening more accessible. By allowing patients to complete important tests from the comfort of their homes, Healthy.io and Geisinger are helping address one of the biggest challenges in kidney care—early detection.

Understanding the Healthy.io and Geisinger Partnership

Healthy.io is a digital health company that develops smartphone-enabled diagnostic solutions, enabling patients to perform certain medical tests at home. Geisinger, a leading healthcare system in the United States, partnered with Healthy.io to improve kidney disease screening by making testing simpler and more convenient.

The partnership focuses on increasing screening rates for individuals at risk of chronic kidney disease, particularly those with diabetes or hypertension. These conditions significantly increase the likelihood of kidney damage, making regular screening essential.

Why Chronic Kidney Disease Screening Matters

Chronic kidney disease affects millions of people worldwide, yet many individuals remain undiagnosed because the disease often develops without noticeable symptoms.

Early detection is important because it can:

  • Slow disease progression
  • Reduce the risk of kidney failure
  • Improve treatment outcomes
  • Lower healthcare costs
  • Reduce cardiovascular complications
  • Improve patients’ quality of life

Regular screening allows healthcare providers to identify kidney problems before they become severe.

Home-Based Screening Improves Accessibility

One of the major highlights presented at AHA 2024 was the success of home-based screening.

Traditional laboratory testing often requires patients to:

  • Schedule appointments
  • Travel to healthcare facilities
  • Take time away from work
  • Wait for laboratory processing

Home testing eliminates many of these barriers by allowing patients to complete the screening process at their convenience.

This convenience can significantly increase participation rates, especially among individuals who face transportation, scheduling, or mobility challenges.

Key Milestone Data Presented

The data shared during the conference demonstrated several encouraging outcomes from the Healthy.io and Geisinger collaboration.

Key findings included:

  • Higher completion rates for kidney health screening
  • Improved patient engagement
  • Increased identification of individuals with elevated kidney disease risk
  • Better follow-up care after abnormal test results
  • More efficient integration of digital health into routine clinical practice

These results suggest that home-based testing can complement traditional healthcare services while improving preventive care.

The Role of Digital Health Innovation

Digital health technologies continue transforming the delivery of medical care.

Healthy.io’s platform combines:

  • Smartphone technology
  • Home testing kits
  • Digital result processing
  • Secure communication with healthcare providers

Patients can complete tests without needing specialized laboratory equipment while clinicians receive standardized results for further evaluation.

This approach simplifies screening while maintaining clinical reliability.

Benefits for Patients

Home-based kidney screening offers several advantages for patients.

These include:

  • Greater convenience
  • Reduced travel requirements
  • Faster access to testing
  • Increased participation in preventive care
  • Better communication with healthcare providers
  • Earlier diagnosis of kidney disease

Making screening easier encourages more people to complete recommended health checks.

Benefits for Healthcare Providers

Healthcare organizations also benefit from digital screening solutions.

Advantages include:

  • Improved population health management
  • Increased screening compliance
  • Earlier clinical intervention
  • Better patient monitoring
  • More efficient resource utilization
  • Enhanced preventive care programs

These improvements can help healthcare systems identify high-risk patients before complications develop.

Chronic Kidney Disease and Heart Health

Kidney disease and cardiovascular disease are closely connected.

Individuals with chronic kidney disease have a significantly higher risk of:

  • Heart attacks
  • Stroke
  • Heart failure
  • High blood pressure
  • Cardiovascular mortality

Likewise, cardiovascular disease can worsen kidney function over time.

This relationship explains why kidney screening was an important topic during the American Heart Association Scientific Sessions.

The Future of Preventive Healthcare

The collaboration between Healthy.io and Geisinger demonstrates how digital innovation is reshaping preventive medicine.

Future developments may include:

  • Expanded home diagnostic testing
  • AI-assisted health monitoring
  • Remote patient management
  • Personalized preventive care
  • Greater integration with electronic health records
  • Improved chronic disease management

As healthcare increasingly shifts toward patient-centered care, digital tools are expected to play an even larger role.

Challenges to Consider

Although home-based screening offers many benefits, successful implementation requires addressing several challenges.

These include:

  • Patient education
  • Digital literacy
  • Internet access
  • Data privacy and security
  • Integration with healthcare systems
  • Ensuring follow-up after abnormal results

Healthcare providers must continue supporting patients throughout the screening process to maximize clinical benefits.

Conclusion

The milestone data presented by Healthy.io and Geisinger at the American Heart Association Scientific Sessions 2024 highlights the growing potential of digital health technologies to improve preventive care. By making kidney disease screening more convenient and accessible through home-based testing, the partnership demonstrates how innovation can increase patient participation, support earlier diagnosis, and improve long-term health outcomes.

As healthcare continues to embrace digital transformation, home diagnostic solutions are likely to become an increasingly important part of chronic disease management. Initiatives like this not only enhance patient convenience but also strengthen healthcare systems’ ability to detect disease earlier, intervene sooner, and ultimately improve the quality of care for individuals at risk of chronic kidney disease and related cardiovascular conditions.

Frequently Asked Questions (FAQs)

What is Healthy.io?

Healthy.io is a digital health company that develops smartphone-enabled home diagnostic solutions designed to make medical testing more accessible and convenient.

Who is Geisinger?

Geisinger is an integrated healthcare system in the United States that provides comprehensive medical care, research, and innovative healthcare programs.

Why is chronic kidney disease screening important?

Early screening helps identify kidney disease before symptoms appear, allowing timely treatment that can slow disease progression and reduce the risk of serious complications.

How does home-based kidney screening work?

Patients receive a home testing kit, complete the test according to instructions, and use digital technology to securely share results with their healthcare provider for evaluation.

Why was this research presented at the American Heart Association Scientific Sessions?

Kidney disease and cardiovascular disease are closely linked. Early kidney disease detection can support better cardiovascular health, making the findings highly relevant to the cardiovascular research community.